Euroapi climbs DB's preference list on 'appealing' features
13/09/2022 09:33
** Deutsche Bank says Euroapi's EAPI.PA investment case
has moved higher up on its preference list following
better-than-expected H1 performance from the drug ingredients
maker, spun off from Sanofi SASY.PA earlier this year
urn:newsml:reuters.com:*:nL8N3081MI urn:newsml:reuters.com:*:nL5N2WY22N
** The broker points to several features which should make
the stock "very appealing" to investors, such as the company's
business model and its robust end markets
** It adds the group's customer demand remained strong,
"especially from customers outside of Sanofi and for the CDMO
(contract development and manufacturing organization) offering,
which saw a significant increase in requests for proposals and
contract wins"
** The broker raises its target price by 10% to EUR 22, and
keeps its "buy" rating
** Euroapi's shares rise 3.6%, sitting on top of France's
SBF 120 Index .SBF120
(Reporing by Federica Mileo)
((Federica.mileo@thomsonreuters.com))